JPRN-UMIN000033132已完成未知
Phase II trial of stereotactic body radiotherapy for non-spine bone metastases. - SBRT for non-spine bone mets.
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital0 个研究点目标入组 35 人开始时间: 2018年6月25日最近更新:
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. The lesion is skull base bone 2. The lesion is radiosensitive tumor 3. Radiation history in the same area with 3 months 4. Serious medical or psychological problems
研究者
相似试验
已完成
2 期
Phase II trial of stereotactic body radiotherapy with a hydrogel spacer for prostate cancerProstate cancerJPRN-UMIN000026213The University of Tokyo Hospital42
进行中（未招募）
1 期
Phase I trial of stereotactic body radiotherapy with concurrent pembrolizumab in metastatic urothelial cancer.Metastatic urothelial cancerEUCTR2016-001263-37-BEZ Gent20
已完成
1 期
A phase I trial of stereotactic body radiotherapy for limited hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000003090Division of Radiation Oncology and division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan12
招募中
1 期
Phase I study of postoperative stereotactic body radiotherapy for prostate cancerprostate cancerJPRN-jRCT1030220062Yamashita Hideomi36
招募中
1 期
Phase I/II study of stereotactic radiotherapy for renal cell cancerJPRN-UMIN000004172niversity of Yamanashi30